Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MedLeanRx vs Primary Clinic (Direct GLP)

MedLeanRx
Graded #66

Higher grade

vs+8.400000000000006
Primary Clinic (Direct GLP)
Graded #219

Lower grade

The verdict

MedLeanRx takes it — 73.9/100 to 65.5/100.

MedLeanRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedLeanRx +9
74
65
Dose & formulationMedLeanRx +39
93
54
Clinical oversightMedLeanRx +2
77
75
Labs & monitoringPrimary Clinic (Direct GLP) +24
52
76
FulfillmentMedLeanRx +4
77
73
Contract termsMedLeanRx +14
55
41
MedLeanRx · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricMedLeanRxPrimary Clinic (Direct GLP)
WeighScore73.9/10065.5/100
GradeCC
Scorecard rank#66#219
Semaglutide$149/mo (starting dose, promotional rate, compounded)$85/mo (0.25-0.75 mg band, membership required, compounded)
Tirzepatide$269/mo (starting dose, compounded)$133/mo (1.25-2.5 mg band, membership required, compounded)
Coverage1 state10 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
MedLeanRx

Graded #66 · C

Strengths

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

Where it loses points

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • The medication price is on top of an $89/mo direct-primary-care membership, which the FAQ states does not include the drug — all-in is about $174/mo for semaglutide and $222/mo for tirzepatide
  • Prices are published as dose BANDS rather than per dose, and the cheapest tirzepatide band starts at 1.25 mg, below the 2.5 mg labelled starting dose
  • The pricing is rendered entirely in JavaScript, so nothing on the page is readable without running the site's bundle
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard